Skip to main content

Table 2 Clinical and laboratory data of 20 pubertal boys with short stature after GH/Letrozole treatment

From: Adult height in pubertal boys with short stature treated with GH/letrozole: a hospital record-based retrospective study

Subject No. Age-ranges (y) BMI (kg/m2) Height SDS for CA Bone age(y) Height SDS for bone age Testis volume(ml) Tanner stage Testosterone (ng/ml) Estradiol (pg/ml) Growth velocity (cm/y) Final height (cm)
1 13–16 26.5 0.75 14.2 -0.59 25.0 5 6.74 1.00 6.9 170.0
2 13–16 24.1 2.38 15.7 0.06 25.0 5 3.54 0.00 6.4 174.0
3 10–13 21.1 1.10 14.5 -1.30 20.0 4 7.14 16.00 11.9 172.5
4 14–17 18.8 0.83 13.4 0.08 25.0 5 7.25 23.00 10.3 175.0
5 11–14 20.7 1.12 14.6 -1.01 15.0 4 6.87 10.00 9.3 172.0
6 13–16 21.7 1.67 16.2 -0.69 21.0 5 11.28 0.00 7.5 170.0
7 12–15 17.9 2.07 14.7 0.01 20.0 4 2.13 5.00 11.4 172.5
8 12–15 23.3 1.80 14.1 0.17 15.0 4 7.16 17.00 10.6 174.5
9 11–14 25.6 1.76 13.5 0.46 21.0 4 7.10 0.00 11.4 175.0
10 10–13 20.3 1.97 13.9 -0.10 18.0 4 a a 12.6 172.0
11 11–14 23.0 1.57 12.9 0.84 25.0 5 10.19 14.00 10.8 170.6
12 14–17 17.9 1.55 15.4 -0.60 20.0 4 4.46 12.00 6.2 173.0
13 13–16 21.4 1.38 14.3 -0.20 25.0 5 3.22 12.00 6.3 167.5
14 10–13 19.1 1.88 14.0 -0.10 25.0 5 7.14 0.00 12.1 173.2
15 14–17 19.9 1.80 18.3 -0.69 15.0 4 10.39 36.00 5.5 169.0
16 13–16 25.1 1.63 14.0 0.14 25.0 5 7.60 8.00 9.8 173.5
17 12–15 23.9 1.97 14.9 -0.08 20.0 4 7.79 5.00 10.9 178.0
18 12–15 19.2 -0.49 12.1 0.15 15.0 4 5.81 14.00 7.4 170.0
19 12–15 26.0 1.55 13.9 0.06 25.0 5 6.57 39.00 8.6 173.0
20 13–16 20.4 2.29 13.5 0.99 25.0 5 6.96 35.00 10.8 178.0
  1. GH Growth hormone, No. number, SDS Standard deviation score, BMI body mass index, CA Chronological age
  2. aData missing